Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for maxillary sinus augmentation
IRCT20120127008830N5Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of simvastatin in Alveolar bone atrophy (ABL) and alveolar process atrophy, sponsored by Tehran University of Medical Sciences. Started Feb 2018; status: completed.
02
Drugs
simvastatin
03
Conditions
Alveolar bone atrophy (ABL)alveolar process atrophy
Beyond the preview
Go deeper on IRCT20120127008830N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120127008830N5.